Dr. Rebecca Auer receives grant from Canadian Cancer Society

News item

Today, the Canadian Cancer Society publicly announced its $450,000 Innovation to Impact Grant to one of BioCanRx’s founding investigator, Dr. Rebecca Auer. The grant will support Dr. Auer’s research in investigating whether oncolytic virus vaccines and other immune-boosting therapies can stop cancer from spreading after surgery.